These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37169576)

  • 41. Dupilumab, A Monoclonal Antibody for Atopic Dermatitis: A Review of Current Literature.
    Blakely K; Gooderham M; Papp K
    Skin Therapy Lett; 2016 Mar; 21(2):1-5. PubMed ID: 27223113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of systemic lupus erythematosus after dupilumab treatment in a case of atopic dermatitis.
    Okune M; Okiyama N; Fukuzono M; Sasaki K; Nomura T
    J Dermatol; 2022 May; 49(5):556-559. PubMed ID: 35224748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A review of dupilumab in the treatment of atopic diseases.
    Thibodeaux Q; Smith MP; Ly K; Beck K; Liao W; Bhutani T
    Hum Vaccin Immunother; 2019; 15(9):2129-2139. PubMed ID: 30785362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of dupilumab in a patient with atopic dermatitis, severe asthma, and HIV infection.
    Brodska P; Panzner P; Sedlacek D; Terl M; Cetkovska P
    Dermatol Ther; 2020 Nov; 33(6):e14159. PubMed ID: 32776586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review.
    Neagu N; Dianzani C; Avallone G; Dell'Aquila C; Morariu SH; Zalaudek I; Conforti C
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):820-835. PubMed ID: 35122335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report.
    Giavina-Bianchi MH; Giavina-Bianchi P; Rizzo LV
    Einstein (Sao Paulo); 2019 Jul; 17(4):eRC4599. PubMed ID: 31291386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial.
    Siegfried EC; Bieber T; Simpson EL; Paller AS; Beck LA; Boguniewicz M; Schneider LC; Khokhar FA; Chen Z; Prescilla R; Mina-Osorio P; Bansal A
    Am J Clin Dermatol; 2021 Mar; 22(2):243-255. PubMed ID: 33655423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term off-label dupilumab in pediatric atopic dermatitis: A case series.
    Treister AD; Lio PA
    Pediatr Dermatol; 2019 Jan; 36(1):85-88. PubMed ID: 30338546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020.
    Martinez-Cabriales SA; Kirchhof MG; Constantinescu CM; Murguia-Favela L; Ramien ML
    Am J Clin Dermatol; 2021 Jul; 22(4):443-455. PubMed ID: 34076879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current and Future Monoclonal Antibodies in the Treatment of Atopic Dermatitis.
    Chun PIF; Lehman H
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):208-219. PubMed ID: 32617839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis.
    Nettis E; Patella V; Lombardo C; Detoraki A; Macchia L; Di Leo E; Carbonara M; Canonica GW; Bonzano L
    Allergy; 2020 Oct; 75(10):2653-2661. PubMed ID: 32424957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dupilumab for atopic dermatitis: evidence to date.
    Rodrigues MA; Nogueira M; Torres T
    G Ital Dermatol Venereol; 2019 Dec; 154(6):696-713. PubMed ID: 31210470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of a case series of adult patients with severe atopic dermatitis treated with dupilumab in Argentina].
    Máspero J; Angles MV; Ardusso L; Brancciforte M; Castro C; Cruz Iturrieta C; Chouela E; De Gennaro MS; Fernández Bussy R; Galimberti ML; Galimberti RL; Gattolin G; Luna PC; Magariños G; Marini MG; Maskin M; Plafnik R; Raimondo N; Russo JP; Sevinsky L; Stringa MF
    Rev Fac Cien Med Univ Nac Cordoba; 2020 Jun; 77(2):94-99. PubMed ID: 32558511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Occupational Chronic Contact Dermatitis Successfully Treated with Dupilumab: A Case Series.
    Slodownik D; Levi A; Lapidoth M; Moshe S
    Dermatology; 2022; 238(6):1073-1075. PubMed ID: 35462358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dupilumab in pediatric dermatology.
    Plachouri KM; Georgiou S
    J Dermatolog Treat; 2022 Mar; 33(2):682-684. PubMed ID: 32602761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis.
    Silverberg JI; Simpson EL; Boguniewicz M; De Bruin-Weller MS; Foley P; Kataoka Y; Bégo-Le-Bagousse G; Chen Z; Shumel B; Chao J; Rossi AB
    Acta Derm Venereol; 2021 Nov; 101(11):adv00585. PubMed ID: 34618162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records.
    Wang C; Kraus CN; Patel KG; Ganesan AK; Grando SA
    Int J Dermatol; 2020 Feb; 59(2):253-256. PubMed ID: 31286499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
    Paller AS; Beck LA; Blauvelt A; Siegfried EC; Cork MJ; Wollenberg A; Chen Z; Khokhar FA; Vakil J; Zhang A; Bansal A; Cyr SL
    Pediatr Dermatol; 2022 Mar; 39(2):187-196. PubMed ID: 35083774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
    Simpson EL; Bieber T; Guttman-Yassky E; Beck LA; Blauvelt A; Cork MJ; Silverberg JI; Deleuran M; Kataoka Y; Lacour JP; Kingo K; Worm M; Poulin Y; Wollenberg A; Soo Y; Graham NM; Pirozzi G; Akinlade B; Staudinger H; Mastey V; Eckert L; Gadkari A; Stahl N; Yancopoulos GD; Ardeleanu M;
    N Engl J Med; 2016 Dec; 375(24):2335-2348. PubMed ID: 27690741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real-life practice.
    Tauber M; Apoil PA; Richet C; Laurent J; De Bonnecaze G; Mouchon E; Cassagne M; Marguery MC; Hegazy S; Konstantinou MP; Severino M; Uthurriague C; Giordano-Labadie F; Didier A; Paul C
    Br J Dermatol; 2019 Jun; 180(6):1551-1552. PubMed ID: 30633329
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.